AI
AMPE

Atom Investors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Atom Investors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-223
Closed -$38K – 360
2021
Q4 		$38K Buy
+223
New +$83.1K 0.01% 254

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Atom Investors's AMPE Position: Q1 2022 in Review

Atom Investors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2022, closing a stake of 223 shares — an estimated $38K sold.

Atom Investors first reported a position in AMPE in Q4 2021 and held it in 1 quarter. The position peaked at $38K in Q4 2021. 128 funds tracked by Wall St. Rank hold AMPE as of Q1 2022.

  • Atom Investors reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2022 after selling out during the quarter.
  • Atom Investors sold 223 Ampio Pharmaceuticals Inc. shares in Q1 2022, an estimated $38K.
  • Atom Investors first reported a position in Ampio Pharmaceuticals Inc. in Q4 2021 and held it in 1 quarter.
  • Atom Investors's Ampio Pharmaceuticals Inc. position peaked at $38K in Q4 2021.
  • 128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2022.

Based on Atom Investors's 13F filing for Q1 2022, filed 16 May 2022.